Pfizer shares sink on weak 2024 revenue, profit forecasts
Pfizer on Wednesday forecast 2024 revenue and profit below Wall Street expectations, sending its shares down 7% in premarket trading even as it raised cost-cut target by $500 million. Sales of Paxlovid and the vaccine Pfizer makes with German partner BioNTech had boosted the company's revenue over…
#pfizer #sandwich